Cellectar Biosciences, Inc. (31) | Business Finance (16)
Browse by Subcategory
Recent Contracts
-
Form of Underwriting Agreement
(Filed With SEC on December 28, 2020)
-
Form of Series D Preferred Stock Certificate
(Filed With SEC on December 28, 2020)
-
Form of Securities Purchase Agreement
(Filed With SEC on December 28, 2020)
-
Form of Registration Rights Agreement
(Filed With SEC on December 28, 2020)
-
Equity Distribution Agreement between Cellectar Biosciences, Inc. and Oppenheimer & Co. Inc., dated August 11, 2020
(Filed With SEC on August 11, 2020)
-
Form of Warrant Agency Agreement
(Filed With SEC on June 5, 2020)
-
Form of Series H Warrant
(Filed With SEC on May 20, 2020)
-
Form of Underwriting Agreement
(Filed With SEC on May 20, 2020)
-
Form of Pre-Funded Warrant
(Filed With SEC on May 20, 2020)
-
Stock Option Agreement with Igor Grachev
(Filed With SEC on March 9, 2020)
-
Stock Option Agreement with Dov Elefant
(Filed With SEC on March 9, 2020)
-
Form of Series F Common Stock Purchase Warrant
(Filed With SEC on May 20, 2019)
-
Form of Series G Common Stock Purchase Warrant
(Filed With SEC on May 20, 2019)
-
Securities Purchase Agreement, dated as of May 16, 2019, by and among Cellectar Biosciences, Inc. and the Purchasers
(Filed With SEC on May 20, 2019)
-
Private Placement Securities Purchase Agreement, dated as of May 16, 2019, by and among Cellectar Biosciences, Inc. and the Purchasers
(Filed With SEC on May 20, 2019)
-
Registration Rights Agreement, dated as of May 16, 2019, by and among Cellectar Biosciences, Inc. and the Purchasers
(Filed With SEC on May 20, 2019)
